Aeterna Zentaris to Present at Upcoming Bloom Burton & Co. Healthcare Investor Conference in Toronto

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\nQUÉBEC CITY, June 11, 2014 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") today announced that the Company's\n Chairman, CEO, David Dodd, will be presenting a corporate overview at\n the Bloom Burton & Co. Healthcare Investor Conference on Wednesday,\n June 18, 2014, at 11:30 am (Eastern), in Room A-B, 4th floor of the Toronto Board of Trade in Toronto, Canada.\n\n\nAbout Aeterna Zentaris Inc.\n\n\nAeterna Zentaris is a specialty biopharmaceutical company engaged in\n developing novel treatments in oncology and endocrinology. The\n Company's pipeline encompasses compounds at various stages of\n development. For more information, visit www.aezsinc.com.\n\n\nSOURCE Aeterna Zentaris Inc.\n\n\n\n Paul Burroughs Director of Communications (418) 652-8525 ext. 406 [email protected] Copyright CNW Group 2014","length":1559,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.